Joseph Michael Fitzgerald insider trades
Open-market stock purchases and sales by Joseph Michael Fitzgerald, EVP & Group Pres, Cardiology at Boston Scientific Corp, from SEC Form 4 filings since Feb 12, 2010.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -46%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 16, 2026 | BSX Boston Scientific Corp | Sold (not open market) | $135K |
| Feb 16, 2026 | BSX Boston Scientific Corp | Bought (not open market) | — |
| Feb 14, 2026 | BSX Boston Scientific Corp | Sold (not open market) | $149K |
| Feb 14, 2026 | BSX Boston Scientific Corp | Bought (not open market) | — |
| Feb 13, 2026 | BSX Boston Scientific Corp | Bought (not open market) | — |
| Feb 13, 2026 | BSX Boston Scientific Corp | Sold (not open market) | $2.5M |
| Feb 13, 2026 | BSX Boston Scientific Corp | Bought (not open market) | — |
| Feb 12, 2026 | BSX Boston Scientific Corp | Sold (not open market) | $119K |
| Feb 12, 2026 | BSX Boston Scientific Corp | Bought (not open market) | — |
| Feb 12, 2026 | BSX Boston Scientific Corp | Bought (not open market) | — |
| Feb 12, 2026 | BSX Boston Scientific Corp | Bought (not open market) | — |
| Nov 14, 2025 | BSX Boston Scientific Corp | Sold (not open market) | — |
| Nov 12, 2025 | BSX Boston Scientific Corp | Sold (not open market) | — |
| Nov 3, 2025 | BSX Boston Scientific Corp | Sold | $363K |
| Nov 3, 2025 | BSX Boston Scientific Corp | Sold | $1.7M |
| Nov 3, 2025 | BSX Boston Scientific Corp | Sold | $2.9M |
| Nov 3, 2025 | BSX Boston Scientific Corp | Bought (not open market) | — |
Companies traded
- BSX Boston Scientific Corp: 1 buy, 30 sales, last Feb 16, 2026
Get free alerts when Joseph Michael Fitzgerald files a new trade →